| Overview |
| bs-70920r |
| Anti-PARK7 Antibody |
| WB, IHC |
| Reacts with the C-terminal region of human and mouse PARK7 (DJ-1). 82% sequence identity to rat PARK7. |
| Human, Mouse |
| Specifications |
| Unconjugated |
| Rabbit |
| Synthetic peptide corresponding to amino acids from the C-terminal region of human PARK7. |
| Polyclonal |
| #REF! |
| IgG |
| Antigen affinity purified |
| PBS + 0.02% NaN3 |
| Recommended that the undiluted antibody be aliquoted into smaller working volumes (10-30 uL/vial depending on usage) upon arrival and stored long term at -20 C or -80 C, while keeping a working aliquot stored at 4 C for short term. Avoid freeze/thaw cycles. Stable for at least 1 year. |
| Target |
| Q99497 |
| Parkinson disease (autosomal recessive, early onset) 7, DJ1 AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 2, ONCOGENE DJ1, DJ-1, Parkinsonism-associated deglycase, zgc:103725 |
| Application Dilution |
| WB |
1:300-5000 |
| IHC |
|
Powered by Bioz